Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (pTyr290) Peptide
-
- Target See all WASP (WAS) products
- WASP (WAS) (Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
- Protein Region
- pTyr290
- Origin
- Human, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-WASP (pY290) Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- WASP (WAS) (Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
- Synonyms
- IMD2 Peptide, SCNX Peptide, THC Peptide, THC1 Peptide, WASP Peptide, U42471 Peptide, WASp Peptide, Wasp Peptide, imd2 Peptide, thc Peptide, thc1 Peptide, was Peptide, wasp Peptide, wu:fk81c08 Peptide, zgc:64164 Peptide, Wiskott-Aldrich syndrome Peptide, neural Wiskott-Aldrich syndrome protein Peptide, wiskott-aldrich syndrome protein Peptide, Wiskott-Aldrich syndrome L homeolog Peptide, Wiskott-Aldrich syndrome (eczema-thrombocytopenia) b Peptide, WAS Peptide, LOC5578888 Peptide, CpipJ_CPIJ006699 Peptide, Was Peptide, was.L Peptide, wasb Peptide
- Background
- IMD2, Wiskott-Aldrich syndrome protein, WASp
- Gene ID
- 7454, 22376
- UniProt
- P42768, P70315
-